首页> 外文期刊>Behavioural Brain Research: An International Journal >WIN 55,212-2 decreases the reinforcing actions of cocaine through CB(1) cannabinoid receptor stimulation.
【24h】

WIN 55,212-2 decreases the reinforcing actions of cocaine through CB(1) cannabinoid receptor stimulation.

机译:WIN 55,212-2通过CB(1)大麻素受体刺激降低可卡因的增强作用。

获取原文
获取原文并翻译 | 示例
           

摘要

CB(1) cannabinoid receptor agonists show a different profile compared to other drugs of abuse on the basis of experimental data that reveal their reinforcing properties. Thus, there are controversial data in the literature concerning the ability of CB(1) receptor agonists to reinforce behavioral responses in experimental animals, i.e. to lower self-stimulation thresholds, and to support self-administration or conditioned place preference. The aim of the present study was to examine the effects of WIN 55,212-2, a potent CB(1) receptor agonist (graded doses 0.1, 0.3, 1mg/kg, i.p.), on the rewarding efficacy of lateral hypothalamic self-stimulation and on the systemic cocaine-induced potentiation of brain-stimulation reward. WIN 55,212-2 did not affect lateral hypothalamic self-stimulation thresholds both in drug nai;ve rats and in rats pretreated with the drug, whereas it produced a significant, dose-dependent decrease in the maximal rate of responding, i.e. in the performance of the animals. Cocaine (5.0mg/kg, i.p.) produced a significant reduction in self-stimulation threshold, without altering maximal rates of responding. Importantly, WIN 55,212-2 attenuated the effect of cocaine at the two higher doses tested. The effects of the CB(1) receptor agonist were reversed by pretreatment with the selective CB(1) receptor antagonist SR 141716A (0.02mg/kg, i.p.) that did not by itself affect cocaine's action. These results indicate that acute stimulation of CB(1) receptors per se does not affect baseline self-stimulation, but reduces the reinforcing effects induced by cocaine. Taken together these findings suggest that cannabinoids may interfere with brain-reward systems responsible for the expression of acute reinforcing properties of drugs of abuse, such as cocaine, and provide evidence that the cannabinoid system could be an interesting drug discovery and development target for the treatment of drug addiction.
机译:CB(1)大麻素受体激动剂与其他滥用药物相比具有不同的特征,其实验数据显示了它们的增强特性。因此,在文献中有关于CB(1)受体激动剂增强实验动物行为反应的能力的争议性数据,即降低自我刺激阈值,支持自我给药或条件性场所偏爱的能力。本研究的目的是研究WIN 55,212-2(一种有效的CB(1)受体激动剂(分级剂量0.1、0.3、1mg / kg,腹腔注射)对下丘脑外侧自刺激和刺激的奖励作用的影响。对全身可卡因诱导的脑刺激奖励的增强作用。 WIN 55,212-2在未用药的大鼠和用该药预处理的大鼠中均不影响下丘脑的侧向自我刺激阈值,而它却使最大反应速率即剂量依赖性显着降低,且呈剂量依赖性。动物们。可卡因(5.0mg / kg,腹腔注射)使自我刺激阈值显着降低,而没有改变最大反应率。重要的是,在测试的两个较高剂量下,WIN 55,212-2减弱了可卡因的作用。用选择性CB(1)受体拮抗剂SR 141716A(0.02mg / kg,i.p.)进行预处理可逆转CB(1)受体激动剂的作用,而该作用本身并不影响可卡因的作用。这些结果表明,急性刺激CB(1)受体本身并不影响基线自我刺激,但会降低可卡因引起的增强作用。综上,这些发现表明,大麻素可能会干扰负责表达滥用药物(例如可卡因)的急性增强特性的大脑奖励系统,并提供证据表明大麻素系统可能是该疗法有趣的药物发现和开发目标瘾。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号